The eclinical solutions market size has grown rapidly in recent years. It will grow from $8.29 billion in 2024 to $9.15 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to growth in healthcare digitalization, electronic health records (ehr), increasing regulatory compliance, increased need for efficiency and productivity, and increased healthcare integration.
The eclinical solutions market size is expected to see rapid growth in the next few years. It will grow to $15.52 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing interoperability and data exchange, telehealth and remote care, value-based care models, growing demand for population health management, and increasing adoption of precision medicine. Major trends in the forecast period include artificial intelligence (ai) in healthcare, technological advancements, innovative solutions, strategic collaborations, and healthcare integration solutions.
The growth of the eclinical solutions market is expected to be propelled by an increase in research and development (R&D) activities. R&D activities involve companies undertaking initiatives to innovate and introduce new clinical products and services. Electronic clinical outcome assessment solutions play a crucial role in supporting R&D activities by electronically capturing outcomes data in clinical trials. According to the Research and Development Survey 2021 conducted by Statistics NZ, R&D expenditure in the business sector reached $2.8 billion in 2021, reflecting a 5% increase from 2020 and an 18% increase from 2019. This upward trend in R&D activities is a significant driver for the eclinical solutions market during the forecast period.
The growth of the eclinical solutions market is further expected to be fueled by the increasing number of clinical trials. Clinical trials, which assess the safety, efficacy, and potential benefits of new medical treatments, interventions, or drugs, are on the rise. eClinical solutions, as computerized platforms designed to streamline and facilitate clinical trial management, play a pivotal role in supporting life sciences organizations worldwide. In May 2023, according to ClinicalTrials.gov, the number of registered clinical trials studies increased from 399,499 in 2022 to 437,533, encompassing all 50 states of the United States and 221 countries globally. The surge in clinical trials, with 53% recorded in non-U.S. locations, is poised to drive the growth of the eclinical solutions market during the forecast period.
Major companies in the eClinical Solutions market are concentrating on developing innovations, such as a comprehensive clinical trial management solution aimed at streamlining the research and development process, enhancing data integrity, and improving regulatory compliance. Comprehensive clinical trial management solutions are integrated software platforms created to facilitate and optimize the planning, execution, and monitoring of clinical trials. For example, in May 2024, EDETEK Inc., a US-based innovative clinical solutions firm, launched CONFORM eClinical Version 5.1, a comprehensive clinical trial management solution designed to enhance and simplify the clinical trial process. This integrated platform includes essential components like electronic data capture, randomization management, and an electronic trial master file, all focused on improving efficiency, data quality, and regulatory compliance. By providing a self-contained system that meets industry standards, CONFORM eClinical Version 5.1 allows sponsors to gain better control over study conduct, resulting in significant cost savings and quicker turnaround times.
Major companies in the eClinical Solutions market are concentrating on developing innovations in eClinical Technologies, such as eClinical Platforms, to enhance data management, improve patient engagement, and streamline clinical trial processes. eClinical platforms are integrated software systems designed to facilitate the management of clinical trials and research studies. For example, in September 2023, Datacubed Health, a US-based eClinical technology firm, launched its eClinical platform app in China through a partnership with AppInChina for deployment across official Android and Apple app stores. This launch highlights the company’s commitment to compliance, as it has established a legal entity in China and obtained the necessary licenses. The app has been tailored to meet local requirements and thoroughly tested for compliance with Chinese network security standards, backed by a secure SaaS infrastructure hosted on AWS Beijing.
In December 2022, RealTime Software Solutions, a software company based in Germany, acquired Complion Inc. for an undisclosed sum. The goal of this acquisition is to enhance eRegulatory capabilities and streamline clinical research operations, thereby improving efficiency and compliance across the industry. Complion Inc., a US-based software firm, provides eSource solutions for clinical data collection, while eClinical Solutions offers tools for data management and analytics.
Major companies operating in the eClinical solutions market include Anju Software Inc., BioClinicia Inc., Parexel International Corporation, CRF Health, Datatrak International Inc., Eclinical Solutions LLC, ERT Clinical, Medidata Solutions Inc., Omnicomm Systems Inc., Veeva Systems Inc., Mednet Solutions, Oracle Corporation, Merge Healthcare Solutions Inc., Saama Technologies Inc., Signant Health, 4G Clinical, MaxisIT Inc., Research Manager, Slope.io Inc., StudyKIK Inc., 360Medlink Inc., Deep 6 AI Inc., Benchmark Research LLC, Clinical Research Management Inc., Curebase Inc., Eclipse Clinical Research LLC, LINEA System Inc., Acceliant Inc., Bio-Optronics Inc., Complion Inc.
eClinical solutions encompass the utilization of computerized tools and associated processes to streamline clinical trial operations by automating tasks that were traditionally manual. This field has evolved to incorporate a diverse range of technologies aimed at supporting various phases of clinical trials, spanning from planning and execution to submissions and data analysis. These solutions play a vital role in the clinical development process by leveraging expertise in clinical technology.
Key types of eClinical solutions include Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platforms, Randomization and Trial Supply Management (RTSM), Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment (eCOA), Safety Solutions, and Electronic Trial Master File (eTMF). Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) involve programs that facilitate the capture and collection of clinical documents. These solutions can be delivered through various modes, such as web-based, cloud-based, and enterprise-based, and are applicable across different development phases, including phase I, phase II, phase III, and phase IV. eClinical solutions find application in diverse sectors, including pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service firms, medical device manufacturers, hospitals, and academic research institutions.
The eclinical solutions market research report is one of a series of new reports that provides eclinical solutions market statistics, including global market size, regional shares, competitors with a eclinical solutions market share, detailed eclinical solutions market segments, market trends and opportunities, and any further data you may need to thrive in the eclinical solutions industry. This eclinical solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
North America was the largest region in the eclinical solutions market in 2024. The regions covered in the eclinical solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the eclinical solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The eClinical solutions market includes revenues earned by entities by eConsent, eTMF, eISF, and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The eclinical solutions market size is expected to see rapid growth in the next few years. It will grow to $15.52 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing interoperability and data exchange, telehealth and remote care, value-based care models, growing demand for population health management, and increasing adoption of precision medicine. Major trends in the forecast period include artificial intelligence (ai) in healthcare, technological advancements, innovative solutions, strategic collaborations, and healthcare integration solutions.
The growth of the eclinical solutions market is expected to be propelled by an increase in research and development (R&D) activities. R&D activities involve companies undertaking initiatives to innovate and introduce new clinical products and services. Electronic clinical outcome assessment solutions play a crucial role in supporting R&D activities by electronically capturing outcomes data in clinical trials. According to the Research and Development Survey 2021 conducted by Statistics NZ, R&D expenditure in the business sector reached $2.8 billion in 2021, reflecting a 5% increase from 2020 and an 18% increase from 2019. This upward trend in R&D activities is a significant driver for the eclinical solutions market during the forecast period.
The growth of the eclinical solutions market is further expected to be fueled by the increasing number of clinical trials. Clinical trials, which assess the safety, efficacy, and potential benefits of new medical treatments, interventions, or drugs, are on the rise. eClinical solutions, as computerized platforms designed to streamline and facilitate clinical trial management, play a pivotal role in supporting life sciences organizations worldwide. In May 2023, according to ClinicalTrials.gov, the number of registered clinical trials studies increased from 399,499 in 2022 to 437,533, encompassing all 50 states of the United States and 221 countries globally. The surge in clinical trials, with 53% recorded in non-U.S. locations, is poised to drive the growth of the eclinical solutions market during the forecast period.
Major companies in the eClinical Solutions market are concentrating on developing innovations, such as a comprehensive clinical trial management solution aimed at streamlining the research and development process, enhancing data integrity, and improving regulatory compliance. Comprehensive clinical trial management solutions are integrated software platforms created to facilitate and optimize the planning, execution, and monitoring of clinical trials. For example, in May 2024, EDETEK Inc., a US-based innovative clinical solutions firm, launched CONFORM eClinical Version 5.1, a comprehensive clinical trial management solution designed to enhance and simplify the clinical trial process. This integrated platform includes essential components like electronic data capture, randomization management, and an electronic trial master file, all focused on improving efficiency, data quality, and regulatory compliance. By providing a self-contained system that meets industry standards, CONFORM eClinical Version 5.1 allows sponsors to gain better control over study conduct, resulting in significant cost savings and quicker turnaround times.
Major companies in the eClinical Solutions market are concentrating on developing innovations in eClinical Technologies, such as eClinical Platforms, to enhance data management, improve patient engagement, and streamline clinical trial processes. eClinical platforms are integrated software systems designed to facilitate the management of clinical trials and research studies. For example, in September 2023, Datacubed Health, a US-based eClinical technology firm, launched its eClinical platform app in China through a partnership with AppInChina for deployment across official Android and Apple app stores. This launch highlights the company’s commitment to compliance, as it has established a legal entity in China and obtained the necessary licenses. The app has been tailored to meet local requirements and thoroughly tested for compliance with Chinese network security standards, backed by a secure SaaS infrastructure hosted on AWS Beijing.
In December 2022, RealTime Software Solutions, a software company based in Germany, acquired Complion Inc. for an undisclosed sum. The goal of this acquisition is to enhance eRegulatory capabilities and streamline clinical research operations, thereby improving efficiency and compliance across the industry. Complion Inc., a US-based software firm, provides eSource solutions for clinical data collection, while eClinical Solutions offers tools for data management and analytics.
Major companies operating in the eClinical solutions market include Anju Software Inc., BioClinicia Inc., Parexel International Corporation, CRF Health, Datatrak International Inc., Eclinical Solutions LLC, ERT Clinical, Medidata Solutions Inc., Omnicomm Systems Inc., Veeva Systems Inc., Mednet Solutions, Oracle Corporation, Merge Healthcare Solutions Inc., Saama Technologies Inc., Signant Health, 4G Clinical, MaxisIT Inc., Research Manager, Slope.io Inc., StudyKIK Inc., 360Medlink Inc., Deep 6 AI Inc., Benchmark Research LLC, Clinical Research Management Inc., Curebase Inc., Eclipse Clinical Research LLC, LINEA System Inc., Acceliant Inc., Bio-Optronics Inc., Complion Inc.
eClinical solutions encompass the utilization of computerized tools and associated processes to streamline clinical trial operations by automating tasks that were traditionally manual. This field has evolved to incorporate a diverse range of technologies aimed at supporting various phases of clinical trials, spanning from planning and execution to submissions and data analysis. These solutions play a vital role in the clinical development process by leveraging expertise in clinical technology.
Key types of eClinical solutions include Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platforms, Randomization and Trial Supply Management (RTSM), Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment (eCOA), Safety Solutions, and Electronic Trial Master File (eTMF). Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) involve programs that facilitate the capture and collection of clinical documents. These solutions can be delivered through various modes, such as web-based, cloud-based, and enterprise-based, and are applicable across different development phases, including phase I, phase II, phase III, and phase IV. eClinical solutions find application in diverse sectors, including pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service firms, medical device manufacturers, hospitals, and academic research institutions.
The eclinical solutions market research report is one of a series of new reports that provides eclinical solutions market statistics, including global market size, regional shares, competitors with a eclinical solutions market share, detailed eclinical solutions market segments, market trends and opportunities, and any further data you may need to thrive in the eclinical solutions industry. This eclinical solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
North America was the largest region in the eclinical solutions market in 2024. The regions covered in the eclinical solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the eclinical solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The eClinical solutions market includes revenues earned by entities by eConsent, eTMF, eISF, and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. eClinical Solutions Market Characteristics3. eClinical Solutions Market Trends And Strategies4. eClinical Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market32. Global eClinical Solutions Market Competitive Benchmarking And Dashboard33. Key Mergers And Acquisitions In The eClinical Solutions Market34. Recent Developments In The eClinical Solutions Market
5. Global eClinical Solutions Growth Analysis And Strategic Analysis Framework
6. eClinical Solutions Market Segmentation
7. eClinical Solutions Market Regional And Country Analysis
8. Asia-Pacific eClinical Solutions Market
9. China eClinical Solutions Market
10. India eClinical Solutions Market
11. Japan eClinical Solutions Market
12. Australia eClinical Solutions Market
13. Indonesia eClinical Solutions Market
14. South Korea eClinical Solutions Market
15. Western Europe eClinical Solutions Market
16. UK eClinical Solutions Market
17. Germany eClinical Solutions Market
18. France eClinical Solutions Market
19. Italy eClinical Solutions Market
20. Spain eClinical Solutions Market
21. Eastern Europe eClinical Solutions Market
22. Russia eClinical Solutions Market
23. North America eClinical Solutions Market
24. USA eClinical Solutions Market
25. Canada eClinical Solutions Market
26. South America eClinical Solutions Market
27. Brazil eClinical Solutions Market
28. Middle East eClinical Solutions Market
29. Africa eClinical Solutions Market
30. eClinical Solutions Market Competitive Landscape And Company Profiles
31. eClinical Solutions Market Other Major And Innovative Companies
35. eClinical Solutions Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
eClinical Solutions Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on eclinical solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for eclinical solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The eclinical solutions market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS); Clinical Trial Management Systems (CTMS); Clinical Analytics Platforms; Randomization and Trial Supply Management (RTSM); Clinical Data Integration Platforms; Electronic Clinical Outcome Assessment (eCOA); Safety Solutions; Electronic Trial Master File (eTMF)2) By Development Phase: Phase I; Phase II; Phase III; Phase IV
3) By Delivery Mode: Web-Based and Cloud-Based; Enterprise-Based
4) By End User: Pharmaceutical and Biopharmaceutical Companies; Contract Research Organizations; Consulting Service Companies; Medical Device Manufacturers; Hospitals; Academic Research Institutions
Subsegments:
1) By Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS): Cloud-based EDC Systems; On-premises EDC Systems; Data Management Software2) By Clinical Trial Management Systems (CTMS): Study Management Systems; Site Management Systems; Budget and Billing Management Systems
3) By Clinical Analytics Platforms: Predictive Analytics Tools; Real-time Data Analytics Solutions; Reporting and Visualization Tools
4) By Randomization and Trial Supply Management (RTSM): Randomization Software; Inventory Management Systems; Supply Chain Management Solutions
5) By Clinical Data Integration Platforms: Data Aggregation Tools; Interoperability Solutions; Data Transformation Software
6) By Electronic Clinical Outcome Assessment (eCOA): Patient-reported Outcome Measures (PROMs); Clinician-reported Outcome Measures (CROMs); Observer-reported Outcome Measures (ObsROs)
7) By Safety Solutions: Pharmacovigilance Software; Adverse Event Reporting Systems; Risk Management Solutions
8) By Electronic Trial Master File (eTMF): Document Management Systems; Compliance Tracking Tools; Workflow Automation Solutions
Key Companies Mentioned: Anju Software Inc.; BioClinicia Inc.; Parexel International Corporation; CRF Health; Datatrak International Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Anju Software Inc.
- BioClinicia Inc.
- Parexel International Corporation
- CRF Health
- Datatrak International Inc.
- Eclinical Solutions LLC
- ERT Clinical
- Medidata Solutions Inc.
- Omnicomm Systems Inc.
- Veeva Systems Inc.
- Mednet Solutions
- Oracle Corporation
- Merge Healthcare Solutions Inc.
- Saama Technologies Inc.
- Signant Health
- 4G Clinical
- MaxisIT Inc.
- Research Manager
- Slope.io Inc.
- StudyKIK Inc.
- 360Medlink Inc.
- Deep 6 AI Inc.
- Benchmark Research LLC
- Clinical Research Management Inc.
- Curebase Inc.
- Eclipse Clinical Research LLC
- LINEA System Inc.
- Acceliant Inc.
- Bio-Optronics Inc.
- Complion Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 9.15 Billion |
| Forecasted Market Value ( USD | $ 15.52 Billion |
| Compound Annual Growth Rate | 14.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
